Consistent with this, the overactivity of the Ang II/AT1 pro-inflammatory axis may induce an increase in the number of released EVs in MetS animals, which is inhibited by the AT1 receptor blocker candesartan, as observed in the present study. Here, AGTR1 is linked to metabolic syndrome.